Business
RAC) share price jumps 13% on study breakthrough
Image source: Getty Images
Shares in Australian pharmaceutical company Race Oncology Ltd (ASX: RAC) jumped higher today and finished 13% in the green.
Investors bid up the Race Oncology share price following study readouts for its lead drug candidate, Zantrene, in a heart safety research…
Continue Reading
-
Business22 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News20 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Noosa News22 hours ago150 jobs in doubt as Bega winds down peanut processing plants in Queensland
-
Business20 hours agoThe best ASX shares to buy and forget for 10+ years